{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:24:04Z","timestamp":1786548244947,"version":"build-2736575974"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1038\/ajg.2010.25","type":"journal-article","created":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T11:25:48Z","timestamp":1267529148000},"page":"866-875","source":"Crossref","is-referenced-by-count":74,"title":["Ischemic Colitis and Complications of Constipation Associated With the Use of Alosetron Under a Risk Management Plan: Clinical Characteristics, Outcomes, and Incidences"],"prefix":"10.14309","volume":"105","author":[{"given":"Lin","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20210210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1046\/j.1365-2036.2000.00684.x","article-title":"A double-blind placebo-controlled study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome.","volume":"14","author":"Bardhan","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"R2-28-20210210","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(00)02033-X","article-title":"The efficacy and safety of alosetron in female patients with irritable bowel syndrome: a randomised, placebo controlled study.","volume":"355","author":"Camilleri","year":"2000","journal-title":"Lancet"},{"key":"R3-28-20210210","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1001\/archinte.161.14.1733","article-title":"A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant IBS.","volume":"161","author":"Camilleri","year":"2001","journal-title":"Archives Int Med"},{"key":"R4-28-20210210","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1046\/j.1365-2036.1999.00610.x","article-title":"Improvement in pain and bowel function in female irritable bowel syndrome patients with alosetron, a 5-HT3-receptor antagonist.","volume":"13","author":"Camilleri","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-28-20210210","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/j.1572-0241.2004.30509.x","article-title":"Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome.","volume":"99","author":"Chey","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R6-28-20210210","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1542-3565(04)00284-8","article-title":"Effect of alosetron on bowel urgency and global symptoms in women with severe, diarrhea-predominant irritable bowel syndrome: analysis of two controlled trials.","volume":"2","author":"Lembo","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R7-28-20210210","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1111\/j.1572-0241.2001.04128.x","article-title":"Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome.","volume":"96","author":"Lembo","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R8-28-20210210","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1111\/j.1572-0241.2007.01282.x","article-title":"A randomized, double-blind, placebo-controlled study to assess efficacy and safety of 0.5mg and 1mg alosetron in women with severe diarrhea-predominant IBS.","volume":"102","author":"Krause","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R9-28-20210210","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cgh.2007.12.015","article-title":"Effects of 5-hydroxytryptamine (serotonin) type 3 antagonists on symptom relief and constipation in nonconstipated irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.","volume":"6","author":"Andresen","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R10-28-20210210","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.clinthera.2008.05.002","article-title":"Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.","volume":"30","author":"Rahimi","year":"2008","journal-title":"Clin Ther"},{"key":"R13-28-20210210","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0016-5085(00)70183-1","article-title":"AGA technical review on intestinal ischemia. American Gastrointestinal Association.","volume":"118","author":"Brandt","year":"2000","journal-title":"Gastroenterology"},{"key":"R14-28-20210210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2982.2006.00861.x","article-title":"Is there an experimental basis for the development of ischaemic colitis as a result of 5-HT3 antagonist treatment?","volume":"19","author":"Camilleri","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"R15-28-20210210","first-page":"A732","article-title":"Alosetron slows colonic transit in patients with irritable bowel syndrome.","volume":"112","author":"Forster","year":"1997","journal-title":"Gastroenterology"},{"key":"R16-28-20210210","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2036.2000.00762.x","article-title":"Alosetron, a 5-HT-3 receptor antagonist, delays colonic transit in patients with IBS and healthy volunteers.","volume":"14","author":"Houghton","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"R17-28-20210210","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/j.1572-0241.2001.04138.x","article-title":"Gender-related differences in slowing colonic transit by a 5-HT3 antagonist in subjects with diarrhea-predominant irritable bowel syndrome.","volume":"96","author":"Viramontes","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R18-28-20210210","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1046\/j.1365-2036.1997.d01-1389.x","article-title":"In vivo effects of the 5-HT3 antagonist alosetron on basal and cholera toxin-induced secretion in the human jejunum: a segmental perfusion study.","volume":"11","author":"Bearcroft","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"R19-28-20210210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1365-2036.2006.03031.x","article-title":"A patient follow-up survey programme for alosetron: assessing compliance to and effectiveness of the risk management programme.","volume":"24","author":"Miller","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"R20-28-20210210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s10350-003-0033-6","article-title":"Outcome of patients with ischemic colitis: review of fifty-three cases.","volume":"47","author":"Medina","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"R21-28-20210210","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/09513590802002163","article-title":"Ischemic colitis in postmenopausal women taking hormone replacement therapy.","volume":"24","author":"Zervoudis","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"R22-28-20210210","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/00000478-199504000-00007","article-title":"Reversible ischemic colitis in young women. Association with oral contraceptive use.","volume":"19","author":"Deana","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R23-28-20210210","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1091-255X(01)80067-6","article-title":"Ischemic colitis in young adults: a single-institution experience.","volume":"5","author":"Preventza","year":"2001","journal-title":"J Gastrointest Surg"},{"key":"R24-28-20210210","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1526-4610.2005.05077_4.x","article-title":"Ischemic colitis associated with naratriptan and oral contraceptive use.","volume":"45","author":"Charles","year":"2005","journal-title":"Headache"},{"key":"R25-28-20210210","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.mcg.0000139037.84310.55","article-title":"Colonic ischemia associated with naratriptan use.","volume":"38","author":"Schwartz","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"R26-28-20210210","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1001\/archinte.158.17.1946","article-title":"Ischemic colitis and sumatriptan use.","volume":"158","author":"Knudsen","year":"1998","journal-title":"Arch Intern Med"},{"key":"R27-28-20210210","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.dld.2004.07.020","article-title":"Ischemic colitis associated with rofecoxib.","volume":"37","author":"Radaelli","year":"2005","journal-title":"Dig Liver Dis"},{"key":"R28-28-20210210","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jbspin.2004.10.004","article-title":"Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum.","volume":"72","author":"Thiefin","year":"2005","journal-title":"Joint Bone Spine"},{"key":"R29-28-20210210","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/j.1572-0241.2004.21436.x","article-title":"Risk factors for colon ischemia.","volume":"99","author":"Walker","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R30-28-20210210","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF02048275","article-title":"Ischemic colitis.","volume":"39","author":"Gandhi","year":"1996","journal-title":"Dis Colon Rectum"},{"key":"R31-28-20210210","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1440-1746.1994.tb01563.x","article-title":"Clinical features in young adult patients with ischaemic colitis.","volume":"9","author":"Matsumoto","year":"1994","journal-title":"J Gastroenterol Hepatol"},{"key":"R32-28-20210210","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2036.2001.00941.x","article-title":"A dose-ranging, placebo-controlled, randomized trial of alosetron in patients with functional dyspepsia.","volume":"15","author":"Talley","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"R33-28-20210210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1046\/j.1365-2125.1998.00777.x","article-title":"Constipation as an adverse effect of drug use in nursing home patients: an overestimate.","volume":"46","author":"van Dijk","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"R34-28-20210210","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1053\/gast.2000.20392","article-title":"AGA technical review on constipation.","volume":"118","author":"Locke","year":"2000","journal-title":"Gastroenterology"},{"key":"R35-28-20210210","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0016-5085(24)05134-5","article-title":"Gastrointestinal transit in thyroid disease.","volume":"86","author":"Shafer","year":"1984","journal-title":"Gastroenterology"},{"key":"R36-28-20210210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF00418848","article-title":"Intestinal non-rotation and pseudoobstruction in myotonic dystrophy: case report and review of the literature.","volume":"11","author":"Sartoretti","year":"1996","journal-title":"Int J Colorectal Dis"},{"key":"R37-28-20210210","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.2337\/diacare.26.5.1553","article-title":"Diabetic autonomic neuropathy.","volume":"26","author":"Vinik","year":"2003","journal-title":"Diabetes Care"},{"key":"R38-28-20210210","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1572-0241.2006.00459.x","article-title":"Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data.","volume":"101","author":"Chang","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R39-28-20210210","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MCG.0b013e31804c7065","article-title":"Clinical significance of colonoscopic findings associated with colonic thickening on computed tomography: is colonoscopy warranted when thickening is detected?","volume":"42","author":"Wolff","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"R40-28-20210210","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1023\/B:DDAS.0000037819.31817.7c","article-title":"Pharmacodynamics and pharmacokinetics of oral contraceptives co-administered with alosetron (Lotronex).","volume":"49","author":"Koch","year":"2004","journal-title":"Dig Dis Sci"},{"key":"R41-28-20210210","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2036.2007.03256.x","article-title":"Pharmacological modulation of gut mucosal and large vessel blood flow.","volume":"25","author":"Kamm","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R42-28-20210210","doi-asserted-by":"crossref","first-page":"148-9","DOI":"10.1016\/S0016-5085(03)80736-9","article-title":"5-HT3 receptor antagonists, alosetron and cilansetron, impair mesenteric blood flow in rats.","volume":"124","author":"Holzer","year":"2003","journal-title":"Gastroenterology"},{"key":"R43-28-20210210","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2982.2007.00938.x","article-title":"Impact of 5-HT3 receptor blockade on colonic haemodynamic responses to ischaemia and reperfusion in the rat.","volume":"19","author":"Grundy","year":"2007","journal-title":"Neurogastroenterol Motil"},{"key":"R44-28-20210210","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1572-0241.2004.04097.x","article-title":"Occurrence of colon ischemia in relation to irritable bowel syndrome.","volume":"99","author":"Cole","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R45-28-20210210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2982.2007.01015.x","article-title":"Assessment of potential risk factors associated with ischaemic colitis.","volume":"20","author":"Chang","year":"2008","journal-title":"Neurogastroenterol Motil"},{"issue":"Suppl C","key":"R47-28-20210210","doi-asserted-by":"crossref","first-page":"C40","DOI":"10.1016\/S0149-2918(98)80007-6","article-title":"Limitations and strengths of spontaneous reports data.","volume":"20","author":"Goldman","year":"1998","journal-title":"Clin Ther"},{"key":"R48-28-20210210","first-page":"49","article-title":"An evaluation of spontaneous adverse drug reaction monitoring systems.","volume":"81","author":"Sachs","year":"1986","journal-title":"Am J Med"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ajg201025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201025","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ajg201025.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.ovid.com\/00000434-201004000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:23:47Z","timestamp":1786544627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201004000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2010.25","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}